Jane Burch
Research Fellow
Email: jane.burch@york.ac.uk
Tel: 01904 321089
Fax: 01904 321041
Jane has worked on numerous systematic reviews of diagnostic and therapeutic interventions for various clinical indications. These have included: the use of neuraminidase inhibitors for the treatment of influenza; stapled haemorrhoidopexy for the treatment of haemorrhoids; the effect of withdrawal of clopidogrel in patients with ischaemic heart disease; and the use of faecal occult blood tests in population screening for colorectal cancer.
Jane has a particular interest in systematic reviews of diagnostic and prognostic tests.Current research projects
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation
The clinical and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision analytical modelSelected publications
McKenna C, Burch J, Suekarran S, Walker S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Lorgelly P, Fenwick L, Palmer S. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure. Health Technol Assess. 2010; 14(24):1-162
Walker S, Burch J, McKenna C, Wright K, Griffin S, Woolacott N. Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11. a Single Technology Appraisal. Centre for Reviews and Dissemination and Centre for Health Economics. 2010.
Burch J, Corbett M, Stock C, Nicholson K, Elliot AJ, Duffy S, Westwood M, Palmer S, Stewart L. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis. 2009; 9(9):537-45
Burch J, Paulden M, Conti S, Stock C, Corbett M, Welton NJ, et al. Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. Health Technol Assess. 2009; 13(58): 1-290